医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

iPug Announces the Launch of iPug Research Suite™

2016年06月10日 AM07:24
このエントリーをはてなブックマークに追加


 

SAN FRANCISCO

iPug, the innovative digital health platform founded in Australia announces the launch of iPug Research Suite™ at the BIO International Convention 2016.

With iPug Research Suite™, iPug recruits and engages targeted participants for high quality and real-time research results. The iPug Research Suite has an intuitive web interface that allows researchers to develop questionnaires, quickly recruit and onboard research participants, export data for analysis as CSV files, or to SPSS and other statistical software systems. In addition, it can access the iPug web and app platform that uses its patent-pending technology to onboard and engage users in research as well as in educational behavior change programs and campaigns. This will allow faster recruitment of research participants, better engagement throughout the study, broader reach than traditional campaigns, and unprecedented data quality for impact evaluations and statistical analyses.

iPug is teaming up with Dr. Andrea C. Gielen, a professor at the Johns Hopkins Bloomberg School of Public Health and the director of the Johns Hopkins Center for Injury Prevention and Policy, and Ms. Eileen McDonald, associate scientist in the Center to roll out a new public health campaign in 2016 called D.O.S.E. (Digital-Opioid-Safety-Education) that will promote safe use, storage, and disposal of opioid pain medications to reduce the risk of addiction, diversion, overdose, and death.

At BIO, iPug will be at the Australian Pavilion from June 6-9th.

About iPug: iPug is the world’s first mobile friendly platform that transforms the way that research is conducted and how public health campaigns are delivered through mobile gamification.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160609006498/en/

CONTACT

iPug
Priya Ghandikota
press@ipug.co

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Scientist.comがインク誌から「米国内で最も急成長中の非公開企業」のトップ10に指名される
  • Urban Drinking Water Challenge 2018 Announces Winners from USA, India and Bangladesh
  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement